Results 231 to 239 of about 79,614 (239)

Human medicines European public assessment report (EPAR): Imatinib medac, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Dermatofibrosarcoma,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Myelodysplastic-Myeloproliferative Diseases,Hypereosinophilic Syndrome, Date of authorisation: 25/09/2013, Revision: 5, Status: Withdrawn

, 2019

openalex   +1 more source

Differential effects of BAFF on B-cell precursor acute lymphoblastic leukemia and Burkitt lymphoma

, 2010
恵子 恩田
openalex  

A Case of Pneumatosis Intestinalis in Refractory Acute Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

, 2011
Suk Hyang Bae, Jin Yeon Hwang, Dongkyun Kim, Min‐Sik Kim, Heejin Kwon, Jin‐Yeong Han, Sung-Hyun Kim   +6 more
openalex  

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lü, Jianping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jia-Rui Zhou, Min Xiong, Ruijuan Sun, Long Jing, Peihua Lu   +10 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Precursor behavior and functional analysis: A brief review

Journal of Applied Behavior Analysis, 2019
exaly  

The transcription factor, BHLHB1 (OLIG 2) induces precursor T cell lymphoblastic lymphoma/leukemia in concert with LMO1 in transgenic mice

, 2005
Ying‐Wei Lin, Ramona Deveney, Peter D. Aplan   +2 more
openalex  

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Arthritis, Psoriatic,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Psoriasis,Arthritis, Rheumatoid,Arthritis, Date of authorisation: 29/03/2017, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imatinib Actavis, imatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic-Myeloproliferative Diseases,Hypereosinophilic Syndrome,Dermatofibrosarcoma, Date of authorisation: 17/04/2013, Revision: 12, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source